Income Statement (TTM)
Avidity Biosciences, Inc. Income Statement shows changes in income and expenses over a period of time. Income Statement data includes Sales and Revenue, Gross Profit, Research and Development (R&D), Selling, General and Administrative Expense (SG&A), Operating Income, Income Tax Expense, Interest Expense, Non-Operating Income, Earnings per Share (EPS), and Shares Outstanding.
All numbers are times 1,000,000 except per share units.
|
2020 09-30 |
2020 12-31 |
2021 03-31 |
2021 06-30 |
2021 09-30 |
2021 12-31 |
2022 03-31 |
2022 06-30 |
2022 09-30 |
2022 12-31 |
2023 03-31 |
2023 06-30 |
2023 09-30 |
2023 12-31 |
2024 03-31 |
2024 06-30 |
2024 09-30 |
2024 12-31 |
2025 03-31 |
2025 06-30 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 6 | 7 | 8 | 9 | 10 | 9 | 8 | 8 | 8 | 9 | 10 | 10 | 10 | 10 | 11 | 11 | 10 | 11 | 9 | 11 |
| Change (%) | 11.44 | 19.83 | 13.11 | 4.53 | -3.02 | -9.75 | -5.10 | 3.99 | 11.04 | 4.75 | 1.43 | 3.43 | -5.68 | 13.70 | -2.49 | -4.55 | 7.71 | -18.08 | 20.19 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Cost Of Sales | 30 | 38 | 53 | 66 | 82 | 101 | 108 | 125 | 138 | 150 | 170 | 173 | 184 | 191 | 210 | 231 | 261 | 304 | 336 | 410 |
| Change (%) | 26.91 | 40.25 | 26.02 | 23.14 | 23.64 | 6.93 | 15.79 | 9.97 | 9.18 | 13.35 | 1.69 | 6.00 | 3.92 | 9.98 | 10.13 | 12.75 | 16.42 | 10.76 | 22.06 | |
| % of Revenue | 486.50 | 554.03 | 648.41 | 722.44 | 851.01 | 1,084.95 | 1,285.41 | 1,568.30 | 1,658.38 | 1,630.57 | 1,764.45 | 1,769.02 | 1,812.95 | 1,997.57 | 1,932.24 | 2,182.31 | 2,577.69 | 2,786.02 | 3,766.67 | 3,825.48 |
| Gross Operating Profit | -24 | -31 | -45 | -57 | -72 | -92 | -100 | -117 | -129 | -141 | -161 | -164 | -174 | -181 | -199 | -221 | -251 | -293 | -327 | -400 |
| Change (%) | 30.92 | 44.74 | 28.38 | 26.13 | 27.19 | 8.62 | 17.55 | 10.37 | 9.06 | 13.91 | 1.71 | 6.15 | 4.48 | 9.79 | 10.81 | 13.58 | 16.77 | 11.83 | 22.11 | |
| % of Revenue | -386.50 | -454.03 | -548.41 | -622.44 | -751.01 | -984.95 | -1,185.41 | -1,468.30 | -1,558.38 | -1,530.57 | -1,664.45 | -1,669.02 | -1,712.95 | -1,897.57 | -1,832.24 | -2,082.31 | -2,477.69 | -2,686.02 | -3,666.67 | -3,725.48 |
| SG&A | 10 | 13 | 17 | 21 | 24 | 26 | 29 | 31 | 35 | 38 | 41 | 45 | 48 | 54 | 56 | 64 | 74 | 86 | 106 | 122 |
| Change (%) | 28.30 | 29.12 | 19.23 | 13.78 | 11.09 | 10.24 | 8.38 | 11.13 | 8.49 | 9.27 | 8.71 | 8.11 | 11.84 | 3.38 | 15.09 | 14.80 | 16.51 | 22.85 | 15.23 | |
| % of Revenue | 172.30 | 198.35 | 213.72 | 225.30 | 245.22 | 280.88 | 343.09 | 391.81 | 418.68 | 409.07 | 426.72 | 457.35 | 478.05 | 566.84 | 515.40 | 608.33 | 731.65 | 791.41 | 1,186.76 | 1,137.80 |
| R&D | ||||||||||||||||||||
| Change (%) | ||||||||||||||||||||
| % of Revenue | ||||||||||||||||||||
| OpEx | 40 | 51 | 70 | 87 | 105 | 127 | 137 | 157 | 173 | 188 | 212 | 218 | 232 | 245 | 266 | 296 | 335 | 390 | 442 | 533 |
| Change (%) | 27.27 | 37.31 | 24.34 | 20.91 | 20.84 | 7.61 | 14.23 | 10.20 | 9.04 | 12.53 | 3.06 | 6.43 | 5.57 | 8.53 | 11.17 | 13.19 | 16.44 | 13.43 | 20.43 | |
| % of Revenue | 658.80 | 752.38 | 862.13 | 947.73 | 1,096.23 | 1,365.83 | 1,628.50 | 1,960.12 | 2,077.07 | 2,039.65 | 2,191.17 | 2,226.37 | 2,291.00 | 2,564.41 | 2,447.64 | 2,790.64 | 3,309.34 | 3,577.43 | 4,953.43 | 4,963.29 |
| Operating Income | -34 | -44 | -62 | -78 | -96 | -118 | -129 | -149 | -164 | -179 | -202 | -208 | -222 | -236 | -255 | -285 | -325 | -379 | -433 | -522 |
| Change (%) | 30.11 | 39.99 | 25.81 | 22.84 | 23.23 | 8.98 | 15.49 | 10.53 | 8.94 | 12.93 | 3.14 | 6.57 | 6.09 | 8.32 | 11.75 | 13.85 | 16.71 | 14.34 | 20.43 | |
| % of Revenue | -558.80 | -652.38 | -762.13 | -847.73 | -996.23 | -1,265.83 | -1,528.50 | -1,860.12 | -1,977.07 | -1,939.65 | -2,091.17 | -2,126.37 | -2,191.00 | -2,464.41 | -2,347.64 | -2,690.64 | -3,209.34 | -3,477.43 | -4,853.43 | -4,863.29 |
| Interest Expense | -5 | -0 | -0 | 0 | 0 | |||||||||||||||
| Change (%) | -95.40 | -37.32 | -100.00 | NaN | ||||||||||||||||
| % of Revenue | -74.66 | -3.08 | -1.61 | 0.00 | 0.00 | |||||||||||||||
| Net Income | -38 | -44 | -62 | -78 | -96 | -118 | -128 | -148 | -162 | -174 | -192 | -193 | -202 | -212 | -229 | -252 | -280 | -322 | -369 | -456 |
| Change (%) | 15.26 | 40.04 | 25.43 | 22.89 | 23.25 | 8.81 | 15.06 | 9.70 | 7.36 | 10.44 | 0.69 | 4.53 | 4.93 | 7.76 | 10.39 | 11.11 | 14.91 | 14.56 | 23.43 | |
| % of Revenue | -631.87 | -653.53 | -763.73 | -846.95 | -995.69 | -1,265.38 | -1,525.48 | -1,849.49 | -1,950.91 | -1,886.33 | -1,988.76 | -1,974.38 | -1,995.34 | -2,219.87 | -2,103.78 | -2,381.82 | -2,772.44 | -2,957.71 | -4,135.99 | -4,247.76 |
Source: Capital IQ
